<HTML>
<HEAD>
<TITLE>sv8</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 18pt">As
filed with the Securities and Exchange Commission on July&nbsp;28, 2005
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Registration No.&nbsp;333-________
</DIV>


<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>




<DIV align="center" style="font-size: 14pt; margin-top: 12pt"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B>
</DIV>

<DIV align="center" style="font-size: 12pt"><B>WASHINGTON, D.C. 20549</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV>
</DIV>

<DIV align="center" style="font-size: 18pt; margin-top: 12pt"><B>FORM S-8</B>
</DIV>


<DIV align="center" style="font-size: 12pt; margin-top: 12pt"><B>REGISTRATION STATEMENT<BR>
UNDER<BR>
THE SECURITIES ACT OF 1933</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV>
</DIV>

<DIV align="center" style="font-size: 24pt; margin-top: 12pt"><B>AMERICAN MEDICAL SYSTEMS HOLDINGS, INC.</B>
</DIV>

<DIV align="center" style="font-size: 10pt">(Exact name of registrant as specified in its charter)</DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="47%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><B>Delaware</B><BR>
(State or other jurisdiction of<BR>
incorporation or organization)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>41-1978822</B><BR>
(I.R.S. Employer<BR>
Identification No.)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="47%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><B>10700 Bren Road West<BR>
Minnetonka, Minnesota</B><BR>
(Address of Principal Executive Offices)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>55343</B><BR>
(Zip Code)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>AMERICAN MEDICAL SYSTEMS HOLDINGS, INC.<BR>
2005 STOCK INCENTIVE PLAN</B><BR>
(Full title of the plan)
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Martin J. Emerson<BR>
President and Chief Executive Officer<BR>
AMERICAN MEDICAL SYSTEMS HOLDINGS, INC.<BR>
10700 Bren Road West<BR>
Minnetonka, MN 55343<BR>
(952)&nbsp;930-6000</B><BR>
(Name, address and telephone number,<BR>
including area code, of agent for service)
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>CALCULATION OF REGISTRATION FEE</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="1%">&nbsp;</TD>
    <TD width="54%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD><!-- VRule -->
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD><!-- VRule -->
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD><!-- VRule -->
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD><!-- VRule -->
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>

    <TD width="1%">&nbsp;</TD>
</TR><TR style="font-size: 1px" valign="bottom">
    <TD nowrap align="left" colspan="23" style="border-bottom: 3px solid #000000">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">    <TD width="1%">&nbsp;</TD>

    <TD nowrap align="left"><B>Title of securities to</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Amount to be</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Proposed maximum offering</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Proposed maximum</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Amount of</B></TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">    <TD width="1%">&nbsp;</TD>

    <TD nowrap align="left"><B>be registered</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>registered (1)</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>price per unit (2)</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>aggregate offering price</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>registration fee (3)</B></TD>
    <TD width="1%">&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
                    <TD valign="top" style="border-top: 2px solid #000000"><DIV style="margin-left:0px; text-indent:-0px">Voting Common
Stock, par value
$0.01 per share
</DIV></TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD nowrap align="right" valign="bottom" style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="right" valign="bottom" style="border-top: 2px solid #000000">6,600,000</TD>
    <TD nowrap valign="bottom" style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD nowrap align="right" valign="bottom" style="border-top: 2px solid #000000">$</TD>
    <TD align="right" valign="bottom" style="border-top: 2px solid #000000">21.53</TD>
    <TD nowrap valign="bottom" style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD nowrap align="right" valign="bottom" style="border-top: 2px solid #000000">$</TD>
    <TD align="right" valign="bottom" style="border-top: 2px solid #000000">142,098,000</TD>
    <TD nowrap valign="bottom" style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD nowrap align="right" valign="bottom" style="border-top: 2px solid #000000">$</TD>
    <TD align="right" valign="bottom" style="border-top: 2px solid #000000">16,724.93</TD>
    <TD nowrap valign="bottom" style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
</TR>
<TR style="font-size: 1px" valign="bottom">
    <TD nowrap align="left" colspan="23" style="border-top: 3px solid #000000">&nbsp;</TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">(1)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>In addition, pursuant to Rule 416(c) under the Securities Act of 1933, as amended, this
registration statement includes an indeterminate number of additional securities as may be
issuable as a result of the anti-dilution provisions of the plan.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">(2)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Estimated solely for the purpose of calculating the amount of the registration fee and
calculated as follows: (i)&nbsp;with respect to options previously granted under the plan, as to
978,642 shares of voting common stock, on the basis of the weighted average exercise price of
such option grants of $19.69 per share, and (ii)&nbsp;with respect to options to be granted under
the plan, on the basis of the average high and low reported sales price of the registrant&#146;s
voting common stock on July&nbsp;21, 2005, as reported by the Nasdaq National Market System.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">(3)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>A filing fee of $2,952.85 was previously paid in connection with shares registered on a Form
S-8, (File No.&nbsp;333-107245) for issuance pursuant to awards under the American Medical Systems
Holdings, Inc. 2000 Equity Incentive Plan. On July&nbsp;28, 2005, 1,270,200 shares underlying this
prior Form S-8 were de-registered pursuant to a post-effective amendment to such registration
statement. Pursuant to Rule&nbsp;457(p), the Company is applying the $937.66 filing fee originally
paid in connection with the de-registered shares as an off-set to the registration fee due
hereunder.</TD>
</TR>

</TABLE>
</DIV>

<DIV style="width: 100%; border-bottom: 1pt solid black; margin-top: 10pt; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>







<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<!-- TOC -->
<A name="toc"><DIV align="CENTER" style="page-break-before:always"><U><B>TABLE OF CONTENTS</B></U></DIV></A>

<P><CENTER>
<TABLE border="0" width="90%" cellpadding="0" cellspacing="0">
<TR>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="76%"></TD>
</TR>
<TR><TD colspan="9"><A HREF="#000">Part II</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#001">Item&nbsp;3. Incorporation of Documents by Reference.</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#002">Item&nbsp;4. Description of Securities.</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#003">Item&nbsp;5. Interests of Named Experts and Counsel.</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#004">Item&nbsp;6. Indemnification of Directors and Officers.</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#005">Item&nbsp;7. Exemptions from Registration Claimed.</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#006">Item&nbsp;8. Exhibits.</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#007">Item&nbsp;9. Undertakings.</A></TD></TR>
<TR><TD colspan="9"><A HREF="#008">SIGNATURES</A></TD></TR>
<TR><TD colspan="9"><A HREF="#009">INDEX TO EXHIBITS</A></TD></TR>
<TR><TD colspan="9"><A HREF="c97040s8exv5w1.htm">Opinion/Consent of Oppenheimer Wolff & Donnelly LLP</A></TD></TR>
<TR><TD colspan="9"><A HREF="c97040s8exv23w1.htm">Consent of Ernst & Young LLP</A></TD></TR>
</TABLE>
</CENTER>
<!-- /TOC -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>





<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>EXPLANATORY NOTE</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">On August&nbsp;11, 2000, a total of 7,423,500* shares of the voting common stock of American
Medical Systems Holdings, Inc. (the &#147;Company&#148;) were registered with the Securities and Exchange
Commission (the &#147;SEC&#148;) by a Registration Statement on Form S-8 (File No.&nbsp;333-43536) in connection
with the American Medical Systems Holdings, Inc. 2000 Equity Incentive Plan (the &#147;Prior Plan&#148;). On
December&nbsp;18, 2001, a total of 2,910,000* additional shares of the voting common stock of the
Company were registered with the SEC by a Registration Statement on Form S-8 (File No.&nbsp;333-75314)
and on July&nbsp;22, 2003, a total of 4,000,000* additional shares of voting common stock of the Company
were registered with the SEC by a Registration Statement on Form S-8 (File No.&nbsp;333-107245) in
connection with the Prior Plan.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">On March&nbsp;29, 2005, the Board of Directors of the Company adopted the American Medical Systems
Holdings, Inc. 2005 Stock Incentive Plan (the &#147;New Plan&#148;). The Board reserved a maximum of
6,600,000 shares of voting common stock for issuance under the New Plan, plus the number of shares
of voting common stock which, as of the effective date of the New Plan, were subject to outstanding
options under the Prior Plan, and which are not thereafter issued or would otherwise have been
available for further issuance under the Prior Plan. The Board also took action to terminate the
Prior Plan as to any future awards thereunder as of the effective date of the New Plan. As of May
5, 2005 (the date of the Company&#146;s Annual Meeting of Stockholders at which the New Plan was
approved and, therefore, the effective date), 13,063,300* shares of the Company&#146;s voting common
stock registered for issuance pursuant to the Prior Plan had been issued or otherwise remained
subject to grants made thereunder. As a result of the termination of the Prior Plan, the remaining
1,270,200* shares have been de-registered pursuant to a post-effective amendment to the last Form
S-8 filed with respect to the Prior Plan, the $937.66 registration fee paid with respect to such
shares is being applied as an off-set to the fees due hereunder. Additional shares under the Prior
Plan may become available in the future and may also be included in the New Plan.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&#091;*Note: On March&nbsp;21, 2005, the Company affected a two-for-one stock split in the form of a 100%
stock dividend. All share and per share numbers are hereby deemed to be adjusted accordingly to
reflect this split.&#093;
</DIV>


<P align="center" style="font-size: 10pt">2
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<!-- link1 "Part II" -->
<DIV align="left"><A NAME="000"></A></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Part II</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>INFORMATION REQUIRED<BR>
IN THE REGISTRATION STATEMENT</B>
</DIV>

<!-- link2 "Item&nbsp;3. Incorporation of Documents by Reference." -->
<DIV align="left"><A NAME="001"></A></DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;3. Incorporation of Documents by Reference.</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The following documents filed by the Company (File No.&nbsp;000-30733) with the SEC are incorporated by
reference in this Registration Statement:
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 9%">(1)&nbsp;Annual Report on Form 10-K for the year ended January&nbsp;1, 2005, as filed with the SEC on
March&nbsp;17, 2005;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 9%">(2)&nbsp;Quarterly Report on Form 10-Q as filed with the SEC on May&nbsp;12, 2005 and as amended on
June&nbsp;13, 2005;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 9%">(3)&nbsp;Current Reports on Form 8-K, as filed with the SEC on February&nbsp;16, 2005, February&nbsp;17,
2005, February&nbsp;28, 2005, April&nbsp;21, 2005, April&nbsp;28, 2005, June&nbsp;6, 2005, July&nbsp;7, 2005 and July
12, 2005;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 9%">(4)&nbsp;All other reports filed by the Company pursuant to Section 13(a) or 15(d) of the
Securities Exchange Act of 1934, as amended, since April&nbsp;2, 2005; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 9%">(5)&nbsp;The description of the Company&#146;s voting common stock contained in the Company&#146;s
Registration Statement on Form 8-A filed with the SEC on May&nbsp;31, 2000, including any
amendments or reports filed for the purpose of updating such descriptions.
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">All documents filed by the Company with the SEC pursuant to Sections&nbsp;13(a), 13(c), 14 and 15(d) of
the Exchange Act after the date of this Registration Statement and prior to the filing of a
post-effective amendment which indicates that all securities offered pursuant to this Registration
Statement have been sold or that deregisters all shares of Common Stock then remaining unsold,
shall be deemed to be incorporated by reference in this Registration Statement and to be a part
hereof from the date of filing of such documents.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The consolidated financial statements of the Company appearing in the Company&#146;s Annual Report (Form
10-K) for the fiscal year ended January&nbsp;1, 2005, have been audited by Ernst &#038; Young LLP,
independent registered public accounting firm, as set forth in their report thereon included therein and incorporated herein
by reference. To the extent that Ernst &#038; Young LLP audits and reports on the financial statements
of the Company issued at future dates, and consents to the use of their reports thereon, such
financial statements also will be incorporated by reference in this Registration Statement.
</DIV>

<!-- link2 "Item&nbsp;4. Description of Securities." -->
<DIV align="left"><A NAME="002"></A></DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;4. Description of Securities.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Not applicable.
</DIV>

<!-- link2 "Item&nbsp;5. Interests of Named Experts and Counsel." -->
<DIV align="left"><A NAME="003"></A></DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;5. Interests of Named Experts and Counsel.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Not applicable.
</DIV>

<!-- link2 "Item&nbsp;6. Indemnification of Directors and Officers." -->
<DIV align="left"><A NAME="004"></A></DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;6. Indemnification of Directors and Officers.</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Company&#146;s Amended and Restated Certificate of Incorporation limits the liability of directors
to the maximum extent permitted by the General Corporation Law of the State of Delaware (the &#147;DGCL&#148;).
</DIV>


<P align="center" style="font-size: 10pt">3
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Reference is made to Section&nbsp;145 of the DGCL, which provides that a corporation may indemnify any
person who was or is a party or is threatened to be made a party to any threatened, pending or
completed action or proceeding, whether civil, criminal, administrative or investigative (other
than an action by or in the right of such corporation), by reason of the fact that such person is
or was a director, officer, employee or agent of the corporation, or is or was serving at its
request in such capacity of another corporation or business organization, against expenses
(including attorneys&#146; fees), judgments, fines and amounts paid in settlement actually and
reasonably incurred by such person in connection with such action, suit or proceeding if such
person acted in good faith and in the best interest of the corporation and, with respect to any
criminal action or proceeding, had no reasonable cause to believe that such person&#146;s conduct was
unlawful. A Delaware corporation may indemnify officers and directors in an action by or in the
right of a corporation under the same conditions, except that no indemnification is permitted
without judicial approval if the officer or director is adjudged to be liable to the corporation.
Where an officer or director is successful on the merits or otherwise in the defense of any action
referred to above, the corporation must indemnify the officer or director against the expenses that
such officer or director actually and reasonably incurred.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Company&#146;s Amended and Restated Certificate of Incorporation provides that, to the extent
permitted by the DGCL, a director of the Company will not be liable to the corporation or its
stockholders for monetary damages for breach of fiduciary duty as a director. Section&nbsp;102(b)(7) of
the DGCL permits a Delaware corporation to include in its certificate of incorporation a provision
eliminating or limiting personal liability of directors of a corporation for monetary damages
arising from breaches of fiduciary duty, except for liability (1)&nbsp;for breaches of a director&#146;s duty
of loyalty to the corporation or its stockholders, (2)&nbsp;for acts or omissions not in good faith or
involving intentional misconduct or a knowing violation of law, (3)&nbsp;for the payment of unlawful
dividends or unlawful stock purchases or redemptions, or (4)&nbsp;for transactions in which a director
received an improper personal benefit.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Company&#146;s Amended and Restated Certificate of Incorporation provides that the Company is
required to indemnify its directors and officers to the maximum extent permitted by law. The
Amended and Restated Certificate of Incorporation also requires the Company to advance expenses
incurred by a director or officer in connection with the defense of any action or proceeding
arising out of that party&#146;s status or service as a director or officer of the Company or as a
director, officer, employee or agent of another corporation, partnership, joint venture, trust,
employee benefit plan or other enterprise, if serving as such at the Company&#146;s request. In
addition, the Certificate of Incorporation permits the Company to secure insurance on behalf of any
director or officer for any liability arising out of his or her actions in a representative
capacity.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">In addition, the Company maintains liability insurance for its directors and officers.
</DIV>

<!-- link2 "Item&nbsp;7. Exemptions from Registration Claimed." -->
<DIV align="left"><A NAME="005"></A></DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;7. Exemptions from Registration Claimed.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">No restricted securities are to be re-offered or resold pursuant to this Registration Statement.
</DIV>

<!-- link2 "Item&nbsp;8. Exhibits." -->
<DIV align="left"><A NAME="006"></A></DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;8. Exhibits.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><U><B>Exhibit&nbsp;No.</B></U>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">4.1</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Amended and Restated Certificate of Incorporation of the Company (incorporated by reference
to Exhibit&nbsp;3.1 of Form 10-K of the Company, SEC File No.&nbsp;000-30733, filed March&nbsp;17, 2005).</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">4.2</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Bylaws of the Company (incorporated by reference to Exhibit&nbsp;3.2 of Form 10-K of the Company,
File No.&nbsp;000-30733, filed March&nbsp;18, 2004).</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">5.1</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Opinion of Oppenheimer Wolff &#038; Donnelly LLP (filed herewith electronically).
</TD>
</TR>
</TABLE>
</DIV>
<P align="center" style="font-size: 10pt">4
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">23.1</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Consent of Ernst &#038; Young LLP (filed herewith electronically).</TD>
</TR>
</TABLE>
</DIV>
<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">23.2</TD>
    <TD width="1%">&nbsp;</TD>
    <TD> Consent of Oppenheimer Wolff &#038; Donnelly LLP (included in Exhibit&nbsp;5.1).</TD>
</TR>
</TABLE>
</DIV>
<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">24.1</TD>
    <TD width="1%">&nbsp;</TD>
    <TD> Power of Attorney (included on the signature page to this Registration Statement).</TD>
</TR>
</TABLE>


</DIV>
<!-- link2 "Item&nbsp;9. Undertakings." -->
<DIV align="left"><A NAME="007"></A></DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;9. Undertakings.</B>
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">(a)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Company hereby undertakes:</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(1)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>To file, during any period in which offers or sales are being made, a
post-effective amendment to this registration statement:</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(i)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>to include any prospectus required by Section&nbsp;10(a)(3) of the
Securities Act;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(ii)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>to reflect in the prospectus any facts or events arising after
the effective date of this registration statement (or the most recent
post-effective amendment thereof) which, individually or in the aggregate,
represent a fundamental change in the information set forth in this
registration statement. Notwithstanding the foregoing, any increase or
decrease in the volume of securities offered (if the total dollar value of
securities offered would not exceed that which was registered) and any
deviation from the low or high end of the estimated maximum offering range may
be reflected in the form of a prospectus filed with the Commission pursuant to
Rule 424(b) if, in the aggregate, the changes in volume and price represent no
more than a 20&nbsp;percent change in the maximum aggregate price set forth in the
&#147;Calculation of Registration Fee&#148; table in the effective registration
statement; and</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(iii)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>to include any material information with respect to the plan
of distribution not previously disclosed in this registration statement or any
material change to such information in this registration statement; provided,
however, that clauses (a)(1)(i) and (a)(1)(ii) do not apply if the information
required to be included in a post-effective amendment by those paragraphs is
contained in periodic reports filed by the Company pursuant to Section&nbsp;13 or
Section 15(d) of the Exchange Act that are incorporated by reference in this
registration statement.</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(2)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>That, for the purpose of determining any liability under the Securities
Act, each such post-effective amendment will be deemed to be a new registration
statement relating to the securities offered therein, and the offering of such
securities at that time will be deemed to be the initial bona fide offering thereof.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(3)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>To remove from registration by means of a post-effective amendment any of
the securities being registered which remain unsold at the termination of the
offering.</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">(b)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Company hereby undertakes that, for purposes of determining any liability under the
Securities Act, each filing of the Company&#146;s annual report pursuant to Section 13(a) or
Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit
plan&#146;s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by
reference in this registration statement will be deemed to be a new registration statement
relating to the securities offered therein, and the offering of such securities at that time
will be deemed to be the initial bona fide offering thereof.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">(c)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Insofar as indemnification for liabilities arising under the Securities Act may be permitted
to directors, officers and controlling persons of the Company pursuant to the foregoing
provisions, or otherwise, the Company has been advised that in the opinion of the SEC such</TD>
</TR>

</TABLE>
</DIV>

<P align="center" style="font-size: 10pt">5
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>indemnification is against public policy as expressed in the Securities Act and is,
therefore, unenforceable. In the event that a claim for indemnification against such
liabilities (other than the payment by the Company of expenses incurred or paid by a
director, officer or controlling person of the Company in the successful defense of any
action, suit or proceeding) is asserted by such director, officer or controlling person
in connection with the securities being registered, the Company will, unless in the
opinion of its counsel the matter has been settled by controlling precedent, submit to a
court of appropriate jurisdiction the question whether such indemnification by it is
against public policy as expressed in the Securities Act and will be governed by the
final adjudication of such issue.</TD>
</TR>

</TABLE>
</DIV>

<P align="center" style="font-size: 10pt">6
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<!-- link1 "SIGNATURES" -->
<DIV align="left"><A NAME="008"></A></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SIGNATURES</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it
has reasonable grounds to believe that it meets all of the requirements of filing on Form S-8 and
has duly caused this Registration Statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in the City of Minnetonka, State of
Minnesota, on July&nbsp;28, 2005.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="46%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="37%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">AMERICAN MEDICAL SYSTEMS HOLDINGS, INC.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Martin J. Emerson
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">Martin J. Emerson&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">President and Chief Executive Officer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">                                         /s/ Carmen L. Diersen
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">Carmen Diersen&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">Executive Vice President, Chief Financial Officer<BR>
and Secretary&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>


<P align="center" style="font-size: 10pt">7
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>POWER OF ATTORNEY</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Each person whose signature appears below constitutes and appoints Martin J. Emerson and
Carmen Diersen, and each of them, his or her true and lawful attorney-in-fact and agent with full
powers of substitution and resubstitution, for and in his or her name, place and stead, in any and
all capacities, to sign any or all amendments (including post-effective amendments) to this
Registration Statement, and to file the same, with all exhibits thereto, and other documents in
connection therewith, with the Securities and Exchange Commission, granting unto said
attorney-in-fact and agent full power and authority to do and perform each and every act and thing
requisite or necessary to be done in and about the premises, as fully to all intents and purposes
as he or she might or could do in person, hereby ratifying and confirming all that said
attorney-in-fact and agent or his substitute or substitutes, may lawfully do or cause to be done by
virtue thereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Pursuant to the requirements of the Securities Act, this Registration Statement has been signed on
July&nbsp;28, 2005 by the following persons in the capacities indicated.
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="44%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="51%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Signature</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" nowrap valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1em">
    <TD align="left" nowrap valign="top">/s/ Martin J. Emerson
<DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV>
Martin J. Emerson</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
President and Chief Executive Officer and
Director<br>(Principal Executive Officer)</TD>
</TR>
<TR valign="bottom" style="padding-top: 1em">
    <TD align="left" nowrap valign="top">/s/ Carmen L. Diersen
<DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV>
Carmen Diersen</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Executive Vice President, Chief
Financial Officer and Secretary<br>
(Principal Financial and Accounting
Officer)</TD>
</TR>
<TR valign="bottom" style="padding-top: 1em">
    <TD align="left" nowrap valign="top">/s/ Douglas W. Kohrs
<DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV>
Douglas W. Kohrs</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Chairman of the Board</TD>
</TR>
<TR valign="bottom" style="padding-top: 1em">
    <TD align="left" nowrap valign="top">/s/ Richard B. Emmitt
<DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV>
Richard B. Emmitt</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Director</TD>
</TR>
<TR valign="bottom" style="padding-top: 1em">
    <TD align="left" nowrap valign="top">/s/ Christopher H. Porter, Ph.D.
<DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV>
Christopher H. Porter, Ph. D</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Director</TD>
</TR>
<TR valign="bottom" style="padding-top: 1em">
    <TD align="left" nowrap valign="top">/s/ Albert Jay Graf
<DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV>
Albert Jay Graf</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Director</TD>
</TR>
<TR valign="bottom" style="padding-top: 1em">
    <TD align="left" nowrap valign="top">/s/ Elizabeth H. Weatherman
<DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV>
Elizabeth H. Weatherman</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Director</TD>
</TR>
<TR valign="bottom" style="padding-top: 1em">
    <TD align="left" nowrap valign="top">/s/ Thomas Timbie
<DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV>
Thomas Timbie</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Director</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">8
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<!-- link1 "INDEX TO EXHIBITS" -->
<DIV align="left"><A NAME="009"></A></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>INDEX TO EXHIBITS</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="8%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="48%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="34%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Item</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Method of Filing</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Amended and Restated Certificate of
Incorporation of Company
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Incorporated by reference to
Exhibit&nbsp;3.1 of Form&nbsp;10-K of
the Company, SEC File No.
000-30733, filed March&nbsp;17,
2005.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Bylaws of Company
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Incorporated by reference to
Exhibit&nbsp;3.2 of Form&nbsp;10-K of
the Company, File No.
000-30733, filed March&nbsp;18,
2004.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">5.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Opinion of Oppenheimer Wolff &#038; Donnelly LLP
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Filed herewith electronically.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">23.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consent of Ernst &#038; Young LLP
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Filed herewith electronically.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">23.2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consent of Oppenheimer Wolff &#038; Donnelly LLP
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Included in Exhibit&nbsp;5.1.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">24.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Power of Attorney
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Included on the signature
page to this Registration
Statement.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt">9
</DIV>


</BODY>
</HTML>
[{"type": "S-8", "sequence": "1", "filename": "c97040s8sv8.htm", "description": "FORM S-8", "secsgml_size_bytes": 47920}]
{"company-data": {"conformed-name": "AMERICAN MEDICAL SYSTEMS HOLDINGS INC", "cik": "0001114200", "assigned-sic": "3842", "irs-number": "134018241", "state-of-incorporation": "DE", "fiscal-year-end": "1229"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-126991", "film-number": "05981761"}, "business-address": {"street1": "10700 BREN ROAD WEST", "city": "MINNETONKA", "state": "MN", "zip": "55343", "phone": "9529334666"}, "mail-address": {"street1": "10700 BREN ROAD WEST", "city": "MINNETONKA", "state": "MN", "zip": "55343"}}
sv8
Table of Contents
As
filed with the Securities and Exchange Commission on July 28, 2005
Registration No. 333-________
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
AMERICAN MEDICAL SYSTEMS HOLDINGS, INC.
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of
incorporation or organization)
41-1978822
(I.R.S. Employer
Identification No.)
10700 Bren Road West
Minnetonka, Minnesota
(Address of Principal Executive Offices)
55343
(Zip Code)
AMERICAN MEDICAL SYSTEMS HOLDINGS, INC.
2005 STOCK INCENTIVE PLAN
(Full title of the plan)
Martin J. Emerson
President and Chief Executive Officer
AMERICAN MEDICAL SYSTEMS HOLDINGS, INC.
10700 Bren Road West
Minnetonka, MN 55343
(952) 930-6000
(Name, address and telephone number,
including area code, of agent for service)
CALCULATION OF REGISTRATION FEE
Title of securities to
Amount to be
Proposed maximum offering
Proposed maximum
Amount of
be registered
registered (1)
price per unit (2)
aggregate offering price
registration fee (3)
Voting Common
Stock, par value
$0.01 per share
6,600,000
$
21.53
$
142,098,000
$
16,724.93
(1)
In addition, pursuant to Rule 416(c) under the Securities Act of 1933, as amended, this
registration statement includes an indeterminate number of additional securities as may be
issuable as a result of the anti-dilution provisions of the plan.
(2)
Estimated solely for the purpose of calculating the amount of the registration fee and
calculated as follows: (i) with respect to options previously granted under the plan, as to
978,642 shares of voting common stock, on the basis of the weighted average exercise price of
such option grants of $19.69 per share, and (ii) with respect to options to be granted under
the plan, on the basis of the average high and low reported sales price of the registrant's
voting common stock on July 21, 2005, as reported by the Nasdaq National Market System.
(3)
A filing fee of $2,952.85 was previously paid in connection with shares registered on a Form
S-8, (File No. 333-107245) for issuance pursuant to awards under the American Medical Systems
Holdings, Inc. 2000 Equity Incentive Plan. On July 28, 2005, 1,270,200 shares underlying this
prior Form S-8 were de-registered pursuant to a post-effective amendment to such registration
statement. Pursuant to Rule 457(p), the Company is applying the $937.66 filing fee originally
paid in connection with the de-registered shares as an off-set to the registration fee due
hereunder.
TABLE OF CONTENTS
Part II
Item 3. Incorporation of Documents by Reference.
Item 4. Description of Securities.
Item 5. Interests of Named Experts and Counsel.
Item 6. Indemnification of Directors and Officers.
Item 7. Exemptions from Registration Claimed.
Item 8. Exhibits.
Item 9. Undertakings.
SIGNATURES
INDEX TO EXHIBITS
Opinion/Consent of Oppenheimer Wolff & Donnelly LLP
Consent of Ernst & Young LLP
Table of Contents
EXPLANATORY NOTE
On August 11, 2000, a total of 7,423,500* shares of the voting common stock of American
Medical Systems Holdings, Inc. (the "Company") were registered with the Securities and Exchange
Commission (the "SEC") by a Registration Statement on Form S-8 (File No. 333-43536) in connection
with the American Medical Systems Holdings, Inc. 2000 Equity Incentive Plan (the "Prior Plan"). On
December 18, 2001, a total of 2,910,000* additional shares of the voting common stock of the
Company were registered with the SEC by a Registration Statement on Form S-8 (File No. 333-75314)
and on July 22, 2003, a total of 4,000,000* additional shares of voting common stock of the Company
were registered with the SEC by a Registration Statement on Form S-8 (File No. 333-107245) in
connection with the Prior Plan.
On March 29, 2005, the Board of Directors of the Company adopted the American Medical Systems
Holdings, Inc. 2005 Stock Incentive Plan (the "New Plan"). The Board reserved a maximum of
6,600,000 shares of voting common stock for issuance under the New Plan, plus the number of shares
of voting common stock which, as of the effective date of the New Plan, were subject to outstanding
options under the Prior Plan, and which are not thereafter issued or would otherwise have been
available for further issuance under the Prior Plan. The Board also took action to terminate the
Prior Plan as to any future awards thereunder as of the effective date of the New Plan. As of May
5, 2005 (the date of the Company's Annual Meeting of Stockholders at which the New Plan was
approved and, therefore, the effective date), 13,063,300* shares of the Company's voting common
stock registered for issuance pursuant to the Prior Plan had been issued or otherwise remained
subject to grants made thereunder. As a result of the termination of the Prior Plan, the remaining
1,270,200* shares have been de-registered pursuant to a post-effective amendment to the last Form
S-8 filed with respect to the Prior Plan, the $937.66 registration fee paid with respect to such
shares is being applied as an off-set to the fees due hereunder. Additional shares under the Prior
Plan may become available in the future and may also be included in the New Plan.
[*Note: On March 21, 2005, the Company affected a two-for-one stock split in the form of a 100%
stock dividend. All share and per share numbers are hereby deemed to be adjusted accordingly to
reflect this split.]
2
Table of Contents
Part II
INFORMATION REQUIRED
IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference.
The following documents filed by the Company (File No. 000-30733) with the SEC are incorporated by
reference in this Registration Statement:
(1) Annual Report on Form 10-K for the year ended January 1, 2005, as filed with the SEC on
March 17, 2005;
(2) Quarterly Report on Form 10-Q as filed with the SEC on May 12, 2005 and as amended on
June 13, 2005;
(3) Current Reports on Form 8-K, as filed with the SEC on February 16, 2005, February 17,
2005, February 28, 2005, April 21, 2005, April 28, 2005, June 6, 2005, July 7, 2005 and July
12, 2005;
(4) All other reports filed by the Company pursuant to Section 13(a) or 15(d) of the
Securities Exchange Act of 1934, as amended, since April 2, 2005; and
(5) The description of the Company's voting common stock contained in the Company's
Registration Statement on Form 8-A filed with the SEC on May 31, 2000, including any
amendments or reports filed for the purpose of updating such descriptions.
All documents filed by the Company with the SEC pursuant to Sections 13(a), 13(c), 14 and 15(d) of
the Exchange Act after the date of this Registration Statement and prior to the filing of a
post-effective amendment which indicates that all securities offered pursuant to this Registration
Statement have been sold or that deregisters all shares of Common Stock then remaining unsold,
shall be deemed to be incorporated by reference in this Registration Statement and to be a part
hereof from the date of filing of such documents.
The consolidated financial statements of the Company appearing in the Company's Annual Report (Form
10-K) for the fiscal year ended January 1, 2005, have been audited by Ernst & Young LLP,
independent registered public accounting firm, as set forth in their report thereon included therein and incorporated herein
by reference. To the extent that Ernst & Young LLP audits and reports on the financial statements
of the Company issued at future dates, and consents to the use of their reports thereon, such
financial statements also will be incorporated by reference in this Registration Statement.
Item 4. Description of Securities.
Not applicable.
Item 5. Interests of Named Experts and Counsel.
Not applicable.
Item 6. Indemnification of Directors and Officers.
The Company's Amended and Restated Certificate of Incorporation limits the liability of directors
to the maximum extent permitted by the General Corporation Law of the State of Delaware (the "DGCL").
3
Table of Contents
Reference is made to Section 145 of the DGCL, which provides that a corporation may indemnify any
person who was or is a party or is threatened to be made a party to any threatened, pending or
completed action or proceeding, whether civil, criminal, administrative or investigative (other
than an action by or in the right of such corporation), by reason of the fact that such person is
or was a director, officer, employee or agent of the corporation, or is or was serving at its
request in such capacity of another corporation or business organization, against expenses
(including attorneys' fees), judgments, fines and amounts paid in settlement actually and
reasonably incurred by such person in connection with such action, suit or proceeding if such
person acted in good faith and in the best interest of the corporation and, with respect to any
criminal action or proceeding, had no reasonable cause to believe that such person's conduct was
unlawful. A Delaware corporation may indemnify officers and directors in an action by or in the
right of a corporation under the same conditions, except that no indemnification is permitted
without judicial approval if the officer or director is adjudged to be liable to the corporation.
Where an officer or director is successful on the merits or otherwise in the defense of any action
referred to above, the corporation must indemnify the officer or director against the expenses that
such officer or director actually and reasonably incurred.
The Company's Amended and Restated Certificate of Incorporation provides that, to the extent
permitted by the DGCL, a director of the Company will not be liable to the corporation or its
stockholders for monetary damages for breach of fiduciary duty as a director. Section 102(b)(7) of
the DGCL permits a Delaware corporation to include in its certificate of incorporation a provision
eliminating or limiting personal liability of directors of a corporation for monetary damages
arising from breaches of fiduciary duty, except for liability (1) for breaches of a director's duty
of loyalty to the corporation or its stockholders, (2) for acts or omissions not in good faith or
involving intentional misconduct or a knowing violation of law, (3) for the payment of unlawful
dividends or unlawful stock purchases or redemptions, or (4) for transactions in which a director
received an improper personal benefit.
The Company's Amended and Restated Certificate of Incorporation provides that the Company is
required to indemnify its directors and officers to the maximum extent permitted by law. The
Amended and Restated Certificate of Incorporation also requires the Company to advance expenses
incurred by a director or officer in connection with the defense of any action or proceeding
arising out of that party's status or service as a director or officer of the Company or as a
director, officer, employee or agent of another corporation, partnership, joint venture, trust,
employee benefit plan or other enterprise, if serving as such at the Company's request. In
addition, the Certificate of Incorporation permits the Company to secure insurance on behalf of any
director or officer for any liability arising out of his or her actions in a representative
capacity.
In addition, the Company maintains liability insurance for its directors and officers.
Item 7. Exemptions from Registration Claimed.
No restricted securities are to be re-offered or resold pursuant to this Registration Statement.
Item 8. Exhibits.
Exhibit No.
4.1
Amended and Restated Certificate of Incorporation of the Company (incorporated by reference
to Exhibit 3.1 of Form 10-K of the Company, SEC File No. 000-30733, filed March 17, 2005).
4.2
Bylaws of the Company (incorporated by reference to Exhibit 3.2 of Form 10-K of the Company,
File No. 000-30733, filed March 18, 2004).
5.1
Opinion of Oppenheimer Wolff & Donnelly LLP (filed herewith electronically).
4
Table of Contents
23.1
Consent of Ernst & Young LLP (filed herewith electronically).
23.2
Consent of Oppenheimer Wolff & Donnelly LLP (included in Exhibit 5.1).
24.1
Power of Attorney (included on the signature page to this Registration Statement).
Item 9. Undertakings.
(a)
The Company hereby undertakes:
(1)
To file, during any period in which offers or sales are being made, a
post-effective amendment to this registration statement:
(i)
to include any prospectus required by Section 10(a)(3) of the
Securities Act;
(ii)
to reflect in the prospectus any facts or events arising after
the effective date of this registration statement (or the most recent
post-effective amendment thereof) which, individually or in the aggregate,
represent a fundamental change in the information set forth in this
registration statement. Notwithstanding the foregoing, any increase or
decrease in the volume of securities offered (if the total dollar value of
securities offered would not exceed that which was registered) and any
deviation from the low or high end of the estimated maximum offering range may
be reflected in the form of a prospectus filed with the Commission pursuant to
Rule 424(b) if, in the aggregate, the changes in volume and price represent no
more than a 20 percent change in the maximum aggregate price set forth in the
"Calculation of Registration Fee" table in the effective registration
statement; and
(iii)
to include any material information with respect to the plan
of distribution not previously disclosed in this registration statement or any
material change to such information in this registration statement; provided,
however, that clauses (a)(1)(i) and (a)(1)(ii) do not apply if the information
required to be included in a post-effective amendment by those paragraphs is
contained in periodic reports filed by the Company pursuant to Section 13 or
Section 15(d) of the Exchange Act that are incorporated by reference in this
registration statement.
(2)
That, for the purpose of determining any liability under the Securities
Act, each such post-effective amendment will be deemed to be a new registration
statement relating to the securities offered therein, and the offering of such
securities at that time will be deemed to be the initial bona fide offering thereof.
(3)
To remove from registration by means of a post-effective amendment any of
the securities being registered which remain unsold at the termination of the
offering.
(b)
The Company hereby undertakes that, for purposes of determining any liability under the
Securities Act, each filing of the Company's annual report pursuant to Section 13(a) or
Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit
plan's annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by
reference in this registration statement will be deemed to be a new registration statement
relating to the securities offered therein, and the offering of such securities at that time
will be deemed to be the initial bona fide offering thereof.
(c)
Insofar as indemnification for liabilities arising under the Securities Act may be permitted
to directors, officers and controlling persons of the Company pursuant to the foregoing
provisions, or otherwise, the Company has been advised that in the opinion of the SEC such
5
Table of Contents
indemnification is against public policy as expressed in the Securities Act and is,
therefore, unenforceable. In the event that a claim for indemnification against such
liabilities (other than the payment by the Company of expenses incurred or paid by a
director, officer or controlling person of the Company in the successful defense of any
action, suit or proceeding) is asserted by such director, officer or controlling person
in connection with the securities being registered, the Company will, unless in the
opinion of its counsel the matter has been settled by controlling precedent, submit to a
court of appropriate jurisdiction the question whether such indemnification by it is
against public policy as expressed in the Securities Act and will be governed by the
final adjudication of such issue.
6
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it
has reasonable grounds to believe that it meets all of the requirements of filing on Form S-8 and
has duly caused this Registration Statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in the City of Minnetonka, State of
Minnesota, on July 28, 2005.
AMERICAN MEDICAL SYSTEMS HOLDINGS, INC.
By:
/s/ Martin J. Emerson
Martin J. Emerson
President and Chief Executive Officer
By:
/s/ Carmen L. Diersen
Carmen Diersen
Executive Vice President, Chief Financial Officer
and Secretary
7
Table of Contents
POWER OF ATTORNEY
Each person whose signature appears below constitutes and appoints Martin J. Emerson and
Carmen Diersen, and each of them, his or her true and lawful attorney-in-fact and agent with full
powers of substitution and resubstitution, for and in his or her name, place and stead, in any and
all capacities, to sign any or all amendments (including post-effective amendments) to this
Registration Statement, and to file the same, with all exhibits thereto, and other documents in
connection therewith, with the Securities and Exchange Commission, granting unto said
attorney-in-fact and agent full power and authority to do and perform each and every act and thing
requisite or necessary to be done in and about the premises, as fully to all intents and purposes
as he or she might or could do in person, hereby ratifying and confirming all that said
attorney-in-fact and agent or his substitute or substitutes, may lawfully do or cause to be done by
virtue thereof.
Pursuant to the requirements of the Securities Act, this Registration Statement has been signed on
July 28, 2005 by the following persons in the capacities indicated.
Signature
Title
/s/ Martin J. Emerson
Martin J. Emerson
President and Chief Executive Officer and
Director
(Principal Executive Officer)
/s/ Carmen L. Diersen
Carmen Diersen
Executive Vice President, Chief
Financial Officer and Secretary
(Principal Financial and Accounting
Officer)
/s/ Douglas W. Kohrs
Douglas W. Kohrs
Chairman of the Board
/s/ Richard B. Emmitt
Richard B. Emmitt
Director
/s/ Christopher H. Porter, Ph.D.
Christopher H. Porter, Ph. D
Director
/s/ Albert Jay Graf
Albert Jay Graf
Director
/s/ Elizabeth H. Weatherman
Elizabeth H. Weatherman
Director
/s/ Thomas Timbie
Thomas Timbie
Director
8
Table of Contents
INDEX TO EXHIBITS
No.
Item
Method of Filing
4.1
Amended and Restated Certificate of
Incorporation of Company
Incorporated by reference to
Exhibit 3.1 of Form 10-K of
the Company, SEC File No.
000-30733, filed March 17,
2005.
4.2
Bylaws of Company
Incorporated by reference to
Exhibit 3.2 of Form 10-K of
the Company, File No.
000-30733, filed March 18,
2004.
5.1
Opinion of Oppenheimer Wolff & Donnelly LLP
Filed herewith electronically.
23.1
Consent of Ernst & Young LLP
Filed herewith electronically.
23.2
Consent of Oppenheimer Wolff & Donnelly LLP
Included in Exhibit 5.1.
24.1
Power of Attorney
Included on the signature
page to this Registration
Statement.
9